Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-08-01
2006-08-01
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S350000, C530S412000, C435S013000, C424S094640
Reexamination Certificate
active
07084113
ABSTRACT:
A method for producing a protein having an antithrombotic activity, which comprises replacing, in a protein that has an amino acid sequence having a homology of not less than 30% to the amino acid sequence of SEQ ID NO: 1 and forms a higher order structure composed of a first β strand (β1), a first a helix (α1), a second α helix (α2), a second β strand (β2), a loop, a third β strand (β3), a fourth β strand (β4) and a fifth β strand (β5) in this order from the amino terminus, at least one amino acid residue in a region from α2 to β2 and/or a region from β3 to β4 so that electric charge of the amino acid residue is changed towards positive direction.
REFERENCES:
patent: 5256559 (1993-10-01), Maraganore et al.
patent: 5744584 (1998-04-01), Scarborough et al.
patent: 5856126 (1999-01-01), Fukuchi et al.
patent: 6010851 (2000-01-01), Mihara et al.
patent: 6015697 (2000-01-01), Mihara et al.
patent: 6207435 (2001-03-01), Mihara et al.
patent: 0 775 711 (1997-05-01), None
Mizuno, H. et al. (1999) Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 A: implication of central loop swapping based on deletion in the linker region. J. Mol. Biol., vol. 289, pp. 103-112.
Dong, A. et al. (2005) Equilibrium titrations of acid-induced unfolding-refolding and salt-induced molten globule of cytochrome c by FT-IR spectroscopy. Arch. Biochem. Biophys., vol. 436, pp. 154-160.
Fukuda, K. et al., (2000) Crystal structure of flavocetin-A, a platelet glycoprotein IB-binding protein, reveals a novel cyclic tetramer of C-type lectin-like heterodimers, Biochemistry vol. 39, pp. 1915-1923.
Zalipsky, S. et al. (1999) New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natur phospholipid, diacyl phosphatidylethanolamine, Bioconjugate Chem. vol. 10, p. 703-707.
Bergeron, R.J. et al. (1997) Development of a Hypusine Reagent for Peptide Synthesis. J. Org. Chem. vol. 62, pp. 3285-3290.
Yee, D. (1998) Introduction to protein folding—the process and factors involved, ProteinDesign, pp. 1-13.
Fukuchi Naoyuki
Futaki Fumie
Gondoh Keiko
Ishikawa Kohki
Kayahara Takashi
Ajinomoto Co. Inc.
Liu Samuel Wei
Weber Jon
LandOfFree
Protein having antithrombotic activity and method for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein having antithrombotic activity and method for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein having antithrombotic activity and method for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3648378